Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 51-60 of 151 for Amyloidosis

Edit search filters
  1. TRITON-PN: A Study To Evaluate The Efficacy And Safety Of Nucresiran In Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

    Rochester, MN

  2. Acoramidis Transthyretin Amyloidosis Prevention Trial In The Young (ACT-EARLY) Study In Asymptomatic Carriers Of A Pathogenic TTR Variant

    Jacksonville, FL

  3. Acoramidis Transthyretin Amyloidosis Prevention Trial In The Young (ACT-EARLY) Study In Asymptomatic Carriers Of A Pathogenic TTR Variant

    Rochester, MN

  4. MAGNITUDE: A Phase 3 Study Of NTLA-2001 In Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

    Rochester, MN

  5. The Study Of An Investigational Drug, Patisiran (ALN-TTR02), For The Treatment Of Transthyretin (TTR)-Mediated Amyloidosis In Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran)

    Rochester, MN

  6. A Research Study To Look At Long-term Treatment With A Medicine Called NNC6019-0001 For People Who Have Heart Failure Due To Transthyretin Amyloidosis

    Scottsdale/Phoenix, AZ

  7. A Study Of The Safety And Effectiveness Of NEOD001 For Treating Previously Treated Patients With Persistent Cardiac Dysfunction Related To Light Chain Amyloidosis

    Jacksonville, FL, Rochester, MN

  8. A Research Study To Look At Long-term Treatment With A Medicine Called NNC6019-0001 For People Who Have Heart Failure Due To Transthyretin Amyloidosis

    Rochester, MN

  9. Alternate Doses And Dosing Schedules Of Belantamab Mafodotin For The Treatment Of Triple-Class Recurrent And/or Refractory Multiple Myeloma

    Jacksonville, FL

  10. A Study Of WVT078 In Patients With Multiple Myeloma

    Rochester, MN

.

Mayo Clinic Footer